Veradermics MANE
NYSE MANE
$120.22 +2.40 (+2.04%)
As of: Sep 30, 2026 · 9:48 AM EDT

Veradermics (MANE) Net Cash Flow (2025 - 2026)

Updated

Veradermics (MANE) posted Net Cash Flow of $150.91 million for Q2 2026, compared with -$23.88 million a year earlier and up 2.9% from the prior quarter.

Analysis

Veradermics (MANE) Net Cash Flow (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Cash Flow at Veradermics was $253 million; for FY2025, it was -$31.32 million.

  • In prior years, Veradermics' Net Cash Flow was $36.78 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -1.27 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -2.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 757.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 1.62 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -4.43 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -722.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 652.90 Mn
10 Veradermics 4.80 Bn 4.80 Bn - 150.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150.91 Mn
Mar 31, 2026 146.61 Mn
Jun 30, 2025 -23.88 Mn
Mar 31, 2025 -20.64 Mn
API Access

Veradermics Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=MANE&period=max&api_key=YOUR_API_KEY